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The intracellular protein p120 catenin aids in maintenance of cell-cell adhesion by 
regulating E-cadherin stability in adherens junctions. Recent studies have shown essential 
roles for the cell-cell adhesion apparatus during development and in several human 
disease states, which has precipitated a rapidly growing interest in the translational 
biology of these molecules. The work described herein advances our knowledge on the 
function of adherens junctions during mammalian development and disease states such as 
injury and neoplastic progression.  
 Chapter 1 provides an overview of established biology of adherens junctions in 
mammalian development, physiology, and cancer. In chapter 2, we identify a crucial role 
for p120 catenin in pancreatic development to include regulation of tubulogenesis, 
branching morphogenesis, acinar cell differentiation, migration of endocrine clusters, and 
actin cytoskeletal organization. Chapter 2 also reports a critical function for p120 catenin 
in regulation of inflammation in neonatal and adult mouse pancreas.     
 Chapter 3 explores the biology of p120 catenin in pancreatic disease states to 
include early pancreatic neoplasia and experimental pancreatitis. Based on literature and 
in vivo evidence linking p120 catenin to both tumor suppressor and metastasis promoting 
activities in various tissue contexts, a conditional mouse model approach was used to 
examine the function of p120 catenin in premalignant pancreatic cancer. Surprisingly, a 
remarkable epithelial cell delamination (also known as basal epithelial cell extrusion) 
phenotype was unmasked in the context of acinar-cell specific deletion of p120 catenin 
and activation of oncogenic Kras in adult mice. This was accompanied by a strong 
desmoplastic response and significant immune cell infiltration. This mouse model 
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unveiled a new mechanism for pancreatic neoplastic epithelial cell invasion. We identify 
S1P/S1pr2 as the key mediator of increased basal epithelial cell extrusion in the context 
of p120 catenin loss in an in vitro system. Chapter 4 presents a brief summary of how the 
data described herein advances the field. Together, these results establish a completely 
novel role for p120 catenin in regulation of basal epithelial cell extrusion and invasion. 
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CHAPTER 1 – INTRODUCTION 
Adherens junctions 
Adherens junctions are one of several transmembrane junctional complexes that mediate 
cell adhesion in polarized epithelial cells (Figure 1.1). The function of adherens junctions 
are to link the actin cytoskeleton of neighboring cells via cadherins and adapter proteins 
like catenins and vinculin. Adherens junction proteins serve roles in tissue homeostasis, 
embryonic development, tissue morphogenesis, and tumorigenesis (Hartsock & Nelson, 
2008; Perez-Moreno & Fuchs, 2006). Accordingly, cadherins and catenins have been the 
subject of intense research and interest since their discovery in the 1970s and 1980s, 
respectively (Yap, Gomez, & Parton, 2015).  
Epithelial integrity is essential for proper organogenesis during development and 
tissue homeostasis. Adherens junctions are an integral part of the maintenance of tight 
cell-cell adhesion in epithelial tissues. The core of the adherens junction in epithelial 
tissues is comprised of E-cadherin, β-catenin, p120 catenin, and α-catenin (Figure 1.2). 
Through homophilic, Ca2+-dependent interactions, extracellular E-cadherin associates 
with E-cadherin molecules of adjacent cells (Shapiro & Weis, 2009). β-catenin binds to 
the catenin-binding domain of intracellular E-cadherin and α-catenin, which associates 
with the actin cytoskeleton. p120 catenin stabilizes epithelial cell adherens junctions 
through its interaction with the juxtamembrane domain of E-cadherin molecules 
(Ishiyama et al., 2010). Cadherin-catenin complexes are rapidly turned over in the 
absence of p120 catenin, demonstrating a crucial role for p120 catenin in cadherin 
stability (Davis, Ireton, & Reynolds, 2003). p120 catenin in the cytoplasm modulates the 
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activities of small Rho family GTPases by inhibiting RhoA and activating Rac1 and 
Cdc42, which together influence cytoskeletal dynamics and cell migration (Anastasiadis 


















            
Figure 1.1. Junctional complexes in polarized epithelial cells. Tight junctions are a 
complex present only in vertebrates; the corresponding complex in invertebrates is 
septate junctions. Tight junctions or zonula occludens and adherens junctions function to 
link the actin cytoskeleton of neighboring cells through adapter proteins including 
claudins and occludens, and cadherins and catenins, respectively. Tight junctions also 
promote formation of an apical barrier in some polarized epithelial cells. Desmosomes 
link the intermediate filaments of neighboring cells through proteins which include 
desmoglein and desmocollin. Focal adhesions and hemidesmosomes connect the cell’s 
actin cytoskeleton and intermediate filaments, respectively, to the extracellular matrix. 















                   
 
Figure 1.2. Adherens junction complex in epithelial cells. Through calcium dependent 
interactions, extracellular E-cadherin homodimerizes at cell membranes. The cytoplasmic 
domain of E-cadherin binds to p120 catenin and β-catenin. β-catenin interacts with α-
catenin, which in turn facilitates association with the actin cytoskeleton. Image used with 









The pancreas is a digestive organ comprising two major compartments: the exocrine 
portion and the endocrine compartment. Pancreatic acinar cells, centroacinar cells and 
ductal cells make up the exocrine component of the pancreas, while alpha cells, beta 
cells, delta cells, PP cells and epsilon cells located in the islets of Langerhans constitute 
the endocrine portion (Figure 1.3). Pancreatic acinar cells synthesize digestive enzymes, 
including proteases like trypsinogen, chymotrypsinogen, elastase and carboxypeptidase, 
pancreatic lipase, nucleases and amylase, which are secreted into the extensive branched 
pancreatic ductal tree and eventually flow into the duodenum to aid in digestion. The 
pancreatic centroacinar and ductal cells produce a bicarbonate-rich secretion when 
stimulated by the hormone secretin, which mixes with the acinar cell secretions to 
compose the pancreatic juice. The bicarbonate secretion functions to neutralize acidic 












Figure 1.3. Hematoxylin and Eosin staining of the human pancreas. The hormone-
producing endocrine gland of the pancreas is composed of the Islets of Langerhans (I). 
Hormones secreted by islet cells are transported via blood vessels (V). The digestive 
exocrine compartment is composed of the acinar cells (A), ductal cells (D) and 









Adherens junctions in mammalian morphogenesis and physiology 
Cadherin family molecules play sundry and important roles in mammalian tissue 
morphogenesis and homeostasis. Cell-cell interactions mediated by E-cadherin during 
embryonic development are critical for blastula formation in many mammals (Fleming, 
Papenbrock, Fesenko, Hausen, & Sheth, 2000). N-cadherin, a classic cadherin from the 
cadherin superfamily and component of adherens junctions, is expressed in many cell 
types in the body including cardiac muscle and neurons. N-cadherin is required for 
numerous morphogenetic processes during embryonic mouse development including 
gastrulation and left-right asymmetry. For pancreas, N-cadherin is expressed in the early 
murine pancreatic epithelium and surrounding mesenchyme at E9.5, while its expression 
is restricted to endocrine populations later during pancreas development. Mouse embryos 
with homozygous loss of N-cadherin in the Pdx-1 endodermal epithelial expression 
domain, which constitutes early multipotent pancreatic progenitors at E8.5, display 
selective dorsal pancreatic agenesis (Esni, Johansson, Radice, & Semb, 2001). N-
cadherin was also shown to be dispensable for lineage specification during pancreas 
development and to regulate beta-cell granule turnover in adult mice (J. K. Johansson et 
al., 2010).    
During tissue morphogenesis and maintenance, catenins such as alpha catenin and 
beta-catenin function in cellular organization and polarity, in part by connecting cadherin 
molecules to cytoskeletal actin filaments. p120 catenin assists in anchoring cadherin 
molecules to the cell membrane thereby regulating their stability and turnover (Davis et 
al., 2003). Dynamic activation of Wnt/beta catenin signaling plays integral roles during 
mouse embryonic development including body axis patterning and cellular fate 
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determination, migration, and proliferation, and regulates tissue turnover in a number of 
adult tissues (Clevers, 2006). Activation of Ctnnb1 during mouse pancreas development 
results in neonatal lethality (Heiser, Lau, Taketo, Herrera, & Hebrok, 2006). Conditional 
deletion of Ctnnb1 during pancreatic organogenesis resulted in a reduction in endocrine 
cell numbers, acute edematous pancreatitis in neonates, but maintenance of adherens 
junctions and desmosomes (Dessimoz, Bonnard, Huelsken, & Grapin-Botton, 2005). 
Additional studies showed a dramatic reduction of exocrine tissue with no apparent effect 
on endocrine cells with conditional deletion of Ctnnb1 during pancreatic organogenesis 
(Murtaugh, Law, Dor, & Melton, 2005; Wells et al., 2007).  
Pancreatic cancer 
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic 
cancer, accounting for more than 90% of cases. The majority of patients diagnosed with 
PDAC have limited options for surgical treatment or chemotherapy. PDAC has the 
lowest 5-year survival rate of any pancreatic cancer, largely because patients are 
commonly diagnosed with metastatic disease, as the tumours metastasize early and do not 
respond well to chemotherapy. For patients for whom surgical intervention is an option, 
the statistics for survival remain grim, as disease recurrence is common, giving them a 5-
year survival rate of about 10-20% (Gopinathan, Morton, Jodrell, & Sansom, 2015). 
While these properties are common to many types of cancer, for pancreatic cancer they 
represent an avenue for potential therapeutic intervention. The discovery of a biological 
mechanism that is primarily responsible for tumour growth and metastases will indelibly 
aid in the discovery of novel therapies for the treatment of pancreatic cancer. 
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Adherens junctions in pancreatic tumorigenesis 
A sequencing study showed 79% of 24 pancreatic adenocarcinomas have mutations in 
homophilic cell adhesion molecules including CDH1 and CDH2, the genes encoding E-
cadherin and N-cadherin, respectively (Jones et al., 2008). The role of cadherins and 
catenins have received a lot of attention regarding their contribution to epithelial-
mesenchymal transition (EMT), a process that may promote invasion and dissemination 
of epithelial tumor cells. Downregulation of E-cadherin and β-catenin at cell membranes 
are hallmarks of EMT (Chaw et al., 2012). Cadherin subtype switching from E-cadherin 
to N-cadherin is commonly associated with EMT. Conditional ablation of N-cadherin and 
simultaneous activation of oncogenic Kras in mouse pancreas results in 
hyperproliferation, accelerated PanIN formation, and early tumor development (Su, Li, 
Shi, Hruban, & Radice, 2015). Additionally, haploinsufficient expression of N-cadherin 
in a mouse model of pancreatic cancer results in significantly increased survival (Su et 
al., 2012).  
Mutations in CTNNB1 have been identified in 100% solid pseudopapillary 
neoplasms (SPN) of the pancreas (Wu et al., 2011). In mice, activation of Ctnnb1 alone, 
which results in up-regulation of Wnt-responsive target genes, is sufficient to drive 
tumorigenesis from pancreatic epithelium and promotes formation of tumors which 
histologically resemble SPN. Interestingly, in this model stabilization of β-catenin in 
cooperation with oncogenic Kras also prevented formation of PanIN (Heiser et al., 2008). 
Additional mouse modeling showed that ligand-mediated activation of the Wnt/β-catenin 




Aims of Thesis 
Interest in adherens junction molecules has precipitated in light of discovery that their 
biological activities include essential roles in mammalian development, normal tissue 
physiology, and the ability to contribute to tumorigenesis when these normal functions 
are perturbed. The in vivo pancreatic function of a key regulator of E-cadherin stability 
and turnover, p120 catenin, has not previously been studied. The aims of this thesis are to 
elucidate the role of p120 catenin in pancreas development, normal physiology, and 
tumorigenesis in an effort to lend insight into its therapeutic potential. An investigation 
into the expression of p120 catenin revealed ubiquitous expression in normal human 
pancreas and downregulation in human pancreatic adenocarcinoma and metastasis, 
observations which warrant further studies to determine the mechanisms by which p120 
catenin potentially contributes to each of these processes. While various biological 
activities can be studied in vitro, a more complete understanding of the functional role of 
p120 catenin requires animal models. The development of transgenic mice with both 
spatially and temporally controlled expression of p120 catenin provided the necessary 
tool to assess the developmental, physiological, and tumorigenic capacity of p120 
catenin. This approach has the added benefit of enabling examination of biologically 
relevant pathways as well as the ability to examine potential effects on multiple organ 
systems in the context of a primary pancreatic insult. Given the established role for 
adherens junctions in disease pathology, future studies which incorporate both functional 
elucidation as well as disease mechanisms have the greatest potential for yielding 




CHAPTER 2 - P120 CATENIN IS REQUIRED FOR NORMAL 




Pancreatic development proceeds from a cluster of endodermal epithelial cells that give 
rise to a highly specialized, heterogeneous endocrine and exocrine organ. The early 
pancreatic bud is enveloped by mesenchyme, which is required for pancreas development 
and is thought to provide inductive signals for the specification of various cell types 
(Golosow & Grobstein, 1962; Landsman et al., 2011). Beginning at E13.5, the mouse 
pancreas changes rapidly during the ‘secondary transition,’ which is marked by dramatic 
increases in endocrine cell numbers and acinar cell differentiation (Rutter et al., 1968). 
Endocrine cells delaminate from the embryonic epithelia, coalesce into early islets, and 
migrate throughout the tissue (Pictet, Clark, Williams, & Rutter, 1972). The developing 
pancreas arborizes to generate a highly branched network of exocrine tissue consisting of 
acini capping the tips of terminal ducts and extending to the main pancreatic duct (Puri & 
Hebrok, 2007; Villasenor, Chong, Henkemeyer, & Cleaver, 2010).  
p120 catenin is a member of the larger catenin gene family that is comprised of 
three subfamilies; p120, beta, and alpha. The p120 subfamily contains 7 members which 
include p120 catenin, ARVCF, δ-catenin, p0071, and plakophilins 1-3 (Zhao, Reynolds, 
& Gaucher, 2011). Like p120 catenin, ARVCF, δ-catenin, and p0071 are capable of 
binding to the juxtamembrane domain of cadherin molecules in adherens junctions 
through their central Armadillo repeat domains, while plakophilins 1-3 primarily function 
in linking the intermediate filaments of cells through desmosomes. p120 catenin, 
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ARVCF, and p0071 are expressed ubiquitously and as multiple isoforms. Expression of 
δ-catenin is thought to be restricted almost entirely to the nervous system (Mariner, 
Wang, & Reynolds, 2000; Pieters, van Hengel, & van Roy, 2012). The biological 
interplay between p120 catenin and its family members is incompletely understood, 
especially during development. 
Deletion of p120 catenin by conventional homologous recombination in mice 
results in embryonic lethality (Davis & Reynolds, 2006). Therefore, a number of studies 
using targeted conditional gene ablation strategies in different murine organ systems have 
revealed various in vivo roles for p120 catenin. In mouse salivary gland organogenesis, 
p120 catenin ablation results in blocked acinar cell differentiation, E-cadherin and β-
catenin reduction, early post-natal death with occlusion of abnormally expanded ducts, 
and progression to a pre-cancer intraepithelial neoplasia phenotype (Davis and Reynolds, 
2006). Deletion of p120 catenin in the epidermis results in cell autonomous activation of 
nuclear factor kappa B (NFkB) signaling, providing evidence to link p120 catenin to 
inflammation (Perez-Moreno et al., 2006). Mice with p120 catenin-null endothelium 
exhibit defects in vascular morphogenesis and angiogenic remodeling, accompanied by 
hemorrhage, and midgestational embryonic lethality (Oas et al., 2010). Studies have also 
revealed critical yet diverse roles for p120 catenin in dental enamel, renal, dendrite, 
mammary gland, and eye development (Bartlett et al., 2010; Elia et al., 2006; Kurley et 
al., 2012; Marciano et al., 2011; Tian et al., 2012). Conditional ablation of p120 catenin 
has also revealed crucial roles in organ homeostasis and tumorigenesis (Perez-Moreno et 
al., 2008; Schackmann et al., 2013; Smalley-Freed et al., 2010; Smalley-Freed et al., 
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2011; Stairs et al., 2011). In these studies, the results of p120 catenin deletion are highly 














































Characterization of p120 catenin expression in mouse pancreas 
We first sought to determine baseline expression of p120 catenin in the embryonic, 
neonatal, and adult mouse pancreas. To accomplish this, we used immunofluorescence 
(IF) with an antibody that recognizes isoforms 1-4 of p120 catenin and also an antibody 
specific for isoforms 1-3 of p120 catenin. Immunolabeling with an antibody that 
recognizes isoforms 1-4 of p120 catenin, E-cadherin, and Vimentin showed ubiquitous 
expression of p120 catenin in both the pancreatic epithelium and the pancreatic 
mesenchyme throughout development, and in the neonatal and adult pancreatic 
epithelium (Figure 2.1). At E12.5 and E14.5, p120 catenin labeling was more highly 
enriched in pancreatic epithelium over pancreatic mesenchyme, except in the endocrine 
clusters at E12.5, which displayed low levels of adherens junction proteins E-cadherin 
and p120 catenin. Immunostaining using an antibody specific for isoforms 1-3 of p120 
catenin showed a labeling pattern indistinguishable from the isoforms 1-4 specific 




Figure 2.1. p120 catenin is expressed ubiquitously in the embryonic, neonatal, and 
adult mouse pancreas. Immunostaining showing p120 catenin expression using an 
antibody specific for isoforms 1-4, E-cadherin, and Vimentin in developing, neonatal, 
and adult mouse pancreas. For E12.5, purple dotted lines show examples of early 
endocrine clusters. For neonatal and adult pancreas, white arrows point to cells indicated 
with a “D” for ducts, “I” indicates islets of Langerhans, and “A” points out acinar cells. 
































































































































































































































































































































































































































































































































































































































Loss of p120 catenin during development disrupts pancreatic tissue architecture 
CPdx1; p120f/wt mice were bred with p120f/f mice, irrespective of gender, to generate CPdx1; 
p120f/f homozygotes. p120f/f mice harbor floxed p120 catenin alleles with loxP sites 
flanking all four known translational start sites; thus, genetic recombination should 
prevent expression of all isoforms of p120 catenin (Davis & Reynolds, 2006). Offspring 
from crosses were born in Mendelian ratios, but 100% of female CPdx1; p120f/f 
homozygotes died during the early post-natal period while male CPdx1; p120f/f 
homozygotes survived to adulthood.  
Pancreatic histology of CPdx1; p120f/f and wild-type littermate controls was 
initially examined at P0, revealing profound changes in pancreatic epithelial architecture 
in homozygous p120f/f pancreata (Figure 2.4A). CPdx1; p120f/f pancreata displayed a 
dramatic expansion of tubular epithelium, which was positive for the epithelial marker 
Cytokeratin 19 (Figure 2.4A,B). A substantial number of Vimentin+ cells were centrally 
located in the pancreata of homozygous p120f/f animals (Figure 2.5). Amylase IF 
demonstrated an overall defect in mature acinar cell differentiation and distribution in 
homozygous p120f/f pancreata when compared to controls (Figure 2.4C). Acinar units in 
homozygous p120f/f animals were peripherally located in early pancreatic lobules and 
often displayed expanded lumens. Transitional structures with both acinar and duct 
morphologies were also evident (Figure 2.4A,B). The abnormal epithelial tubules and 
transitional structures morphologically resembled areas of ADM, which occur in the 
human pancreas in the setting of either pancreatitis or early pancreatic cancer.  
IF demonstrated epithelial-specific loss of p120 catenin in homozygous p120f/f 
pancreata (Figure 2.4D). As expected, expression of p120 catenin in the pancreatic 
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mesenchyme was unaffected (Figure 2.4D). We observed a small degree of mosaicism 
for recombination of the floxed p120 catenin allele during development. Epithelium 
retaining p120 catenin accounted for 6.07% ± 2.49% pancreatic cells during development 
(n=7) and 59.77% ± 3.31% pancreatic cells in CPdx1; p120f/f adult males (n=6). This 
suggests that there may be a selection bias for cells that retain expression of p120 catenin. 
Islets were abnormally distributed throughout the tissue in a pattern such that they 
surrounded the central Vimentin+ cells in homozygous p120f/f pancreata. The 
differentiation of α and β cells, marked by Glucagon and C-peptide, respectively, was 
unaffected throughout embryonic development and in the neonatal pancreas (Figure 2.4E 
and data not shown). No difference was observed in the number of proliferating cells or 
cells undergoing apoptosis in the pancreatic epithelial or mesenchymal compartments 
when comparing wild-type and homozygous p120f/f animals, as examined by cleaved 
Caspase-3 and Ki67 IF (Figure 2.6, 2.7). CPdx1; p120f/wt pancreata were histologically 
indistinguishable from wild-type pancreata both during development and in adulthood, 
suggesting that a single wild-type allele of p120 catenin is sufficient for normal 
pancreatic development and homeostasis (data not shown).  
 
Loss of p120 catenin causes inflammation in the neonatal and adult pancreas  
The overt phenotype observed at P0 resembled pancreatitis, with regions containing 
abundant Vimentin+ cells (Figure 2.5), expanded epithelial tubules, and ADM-like 
transitional structures. Therefore, we next hypothesized that p120 catenin loss might 
induce inflammation in the neonatal pancreas. To test this hypothesis, we stained for 
CD45 in CPdx1; p120f/f and wild-type control pancreata. Abundant CD45+ cells were 
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detected in CPdx1; p120f/f P0 pancreata but not wild-type controls, indicating the 
recruitment of an inflammatory infiltrate in CPdx1; p120f/f pancreata (Figure 2.4F). In an 
effort to understand the mechanism of induction of inflammation in neonatal pancreas, 
we next stained for a known regulator of inflammation that has been previously 
associated with p120 catenin loss and states of pancreatic inflammation, NF-kB (Perez-
Moreno et al., 2006; Rakonczay, Hegyi, Takacs, McCarroll, & Saluja, 2008; Stairs et al., 
2011). NF-kB was detected in ductal epithelium in wild-type pancreata as well as in 
expanded ductal epithelium in CPdx1; p120f/f pancreata at P0 (Figure 2.4G). As incorrect 
regulation of NF-kB has been linked to dysregulation of the immune system and 
inflammation (Perez-Moreno et al., 2006; Stairs et al., 2011), widespread pancreatic 
upregulation of NF-kB in expanded ductal epithelium of CPdx1; p120f/f pancreata may 
represent a possible mechanism for the induction of inflammation. 
We next sought to determine if p120 catenin also regulated inflammation in adult 
pancreas. We examined the pancreatic histology of cohorts of animals ranging in age 
from 1 to 12 months. At 1 month of age, 2/4 CPdx1; p120f/f males displayed frank 
pancreatitis (Figure 2.8). Over time, these animals also developed dilated main pancreatic 
ducts, chronic pancreatitis, ADM, and mucinous metaplasia resembling PanIN1a, with 
incomplete penetrance (4 out of 7 mice) (Figure 2.8). Remaining adult homozygous 
p120f/f pancreata were histologically normal. Adult CPdx1; p120f/f animals also displayed 
abundant CD45+ cells in regions characterized by pancreatitis (Figure 2.8). Incomplete 
penetrance of the phenotype in adult pancreata might be influenced by the degree of 
mosaicism for loss of p120 catenin. Immunolabeling for p120 catenin revealed that ADM 
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and mucinous metaplastic lesions lack p120 catenin, suggesting that these lesions may 












Figure 2.4. Characterization of p120 
catenin deletion in neonatal P0 mice. (A) 
H&E staining showed disruption of pancreatic 
tissue architecture in homozygous p120f/f 
animals. A magnified image of an abnormal 
transitional structure is shown. (B) IHC 
demonstrated that expanded ductal epithelium in 
homozygous p120f/f pancreata is Cytokeratin 19 
positive. (C) Amylase IF showed aberrant acinar 
cell differentiation in CPdx1; p120f/f pancreata. 
(D) IF imaging documented epithelial-specific p120 catenin deletion. In the CPdx1; p120f/f 
figure, the top right yellow arrow points to a rare p120 catenin-expressing epithelial cell. 
The left yellow arrow points to a p120 catenin-expressing non-epithelial cell. The red 
arrow in the inset shows epithelia in CPdx1; p120f/f pancreas that lack p120 catenin. Note 
that p120 catenin staining is nearly completely absent in CPdx1; p120f/f epithelial pancreas, 
with very few cells mosaic for p120 catenin expression. Muc1 and Laminin provide clear 
boundaries for distinction of apical and basal regions of the pancreatic epithelium. (E) IF 
of C-peptide and Glucagon demonstrated abnormal islet distribution in homozygous 
p120f/f pancreas. Identical sections were stained with H&E to demonstrate tissue context, 
and white boxes show corresponding islets. (F) CD45 IHC revealed the recruitment of an 
inflammatory infiltrate in CPdx1; p120f/f pancreas, but not in wild-type controls. In the 
CPdx1; p120f/f bottom panel, yellow arrows point to CD45+ cells. (G) NF-kB signaling was 
detected in the ductal epithelium of both wild-type and homozygous p120f/f pancreas, 






































































































Figure 2.5. Homozygous p120f/f pancreata display increased Vimentin+ cells and 
duct-like epithelium during development. Expansion of a centralized Vimentin+ cluster 
of cells and DBA+ epithelium in homozygous p120f/f pancreas was evident as early as 
E14.5. Some expanded epithelial tubules lost expression of the ductal marker DBA at 


































   
Figure 2.6. Apoptosis is comparable in CPdx1; p120f/f and littermate control 
pancreata throughout development. (A-C) No difference was detected in Cleaved 
Caspase-3 staining throughout development in CPdx1; p120f/f and littermate control 








































p120 catenin is required for normal pancreatic tubulogenesis and branching 
morphogenesis 
To examine the p120 catenin loss-of-function phenotype during development, we next 
undertook a histological examination of wild-type and homozygous p120f/f pancreata in a 
developmental series from E12.5 through E17.5. CPdx1; p120f/f pancreata displayed 
decreased ramification of branches and expanded epithelial tubule lumen diameter 
throughout development (Figure 2.9A). Aberrant tubulogenesis became evident as early 
as E12.5 and epithelial tubules continued to show expanded lumens through E17.5. An 
increased proportion of duct-like epithelium became evident at E14.5 (Figure 2.5) and 
was found distributed throughout the tissue by E16.5 (Figure 2.9A). Proper acinar cell 
differentiation was impeded throughout development in homozygous p120f/f animals.  
 As we identified that homozygous deletion of p120 catenin resulted in the 
recruitment of an inflammatory environment during pancreatogenesis, we next asked if 
the aberrant tubulogenesis evident at E12.5 would still occur in the absence of an 
inflammatory infiltrate. To address this question, we employed a double fluorescent 
mTmG reporter allele (hereafter denoted as “mTmG”) to visualize the dynamics of 
pancreatic tubulogenesis in dissected pancreatic anlagen in an inflammation-free in vitro 
setting. CPdx1; p120f/wt; mTmGTg/Tg mice were bred with p120f/wt mice to generate CPdx1; 
p120wt/wt; mTmGTg/wt, CPdx1; p120f/wt; mTmGTg/wt, and CPdx1; p120f/f; mTmGTg/wt mice. 
Pancreatic rudiments including surrounding mesenchyme, caudal stomach, and proximal 
duodenum were dissected at E11.5 and cultured for up to 7 days as previously described 
(Puri & Hebrok, 2007). Aberrant pancreatic tubulogenesis similar to that observed in vivo 
was also found to occur in vitro in CPdx1; p120f/f; mTmGTg/wt mice and not in wild-type 
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controls. This suggests that the aberrant pancreatic tubulogenesis observed in 
homozygous p120f/f mice occurred even in the absence of concomitant inflammation 
(Figure 2.9B). As expected given their normal histological phenotype in vivo, pancreatic 
explants from CPdx1; p120f/wt; mTmGTg/wt mice recapitulated normal pancreatic 
tubulogenesis in vitro (data not shown).  
 
Pancreatic progenitor markers are retained in expanded tubular epithelium  
Because we identified an alteration in the relative abundance of specific pancreatic cell 
types in CPdx1; p120f/f animals, we next evaluated expression of known progenitor 
markers in developing pancreatic epithelia as a means to assess progenitor differentiation. 
We examined the pancreatic progenitor markers Sox9, Pdx1, and Aldh1 in a 
developmental series using IF and immunohistochemistry (IHC). Pdx1 and Sox9 were 
expressed in the vast majority of pancreatic epithelial cells at E12.5. During 
development, Pdx1 expression gradually became restricted to endocrine cells, while Sox9 
expression became restricted to duct-like epithelium and centroacinar cells (Figure 
2.10A). Pdx1 localization in homozygous p120f/f pancreata is unaltered in the developing 
pancreas when compared to wild-type controls (Fig 2.10A). Between E12.5 and E14.5, 
Aldh1 was expressed in the tips of normal branching pancreatic epithelia (Figure 2.10B) 
(Rovira et al., 2010). By P0, wild-type Aldh1 expression was restricted to endocrine cells, 
a subset of ductal cells, and centroacinar cells (Figure 2.10B). In the absence of p120 
catenin, Aldh1 was expressed in the expanded tubular epithelium throughout 
development, as was Sox9 (Figure 2.10A, 2.10B). Since the early pancreatic progenitor 
marker Aldh1 is expressed in a subset of ductal cells at P0 in wild-type pancreata, 
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continued widespread expression of Aldh1 in expanded duct-like epithelium of 
homozygous p120f/f pancreata might represent a more underdeveloped, undifferentiated 
cellular state suggestive of disrupted progenitor differentiation, as has been previously 
reported for forced ongoing expression of the early pancreatic progenitor marker Sox9 
(Seymour et al., 2007).  
 
Loss of p120 catenin alters cytoskeletal organization but not cell polarity 
 
As an additional means to assess the p120 catenin loss-of-function phenotype, we next 
undertook an examination of apical and basal markers in CPdx1; p120f/f and control 
pancreata. MUC1 is a transmembrane glycoprotein with extensive O-glycosylation that is 
localized to the apical surface of pancreatic epithelial cells (Hollingsworth & Swanson, 
2004; X. Liu, Yi, et al., 2014). We examined localization of the apical marker MUC1 at 
P0 in CPdx1; p120f/f and littermate control pancreata by IF and found that MUC1 was 
localized apically in both homozygous p120f/f animals and wild-type controls in both 
pancreatic ducts and acinar cells (Figure 2.11, 2.12). Phalloidin binds specifically to f-
actin filaments, and Phalloidin has been shown to be localized apically and laterally in 
pancreatic acinar cells (O'Konski & Pandol, 1990; Wulf, Deboben, Bautz, Faulstich, & 
Wieland, 1979). We found that Phalloidin localization was apical, lateral, and basal in 
ductal epithelia, and apical in the acini of CPdx1; p120f/f pancreata at P0, which differs 
from the apical localization of Phalloidin in ducts of wild-type pancreata (Figure 2.11).  
In an effort to understand atypical actin cytoskeleton organization in expanded 
ductal epithelium of CPdx1; p120f/f pancreata, we next assessed localization of PKCζ, a 
known cytoplasmic regulator of actin cytoskeleton dynamics (Even-Faitelson & Ravid, 
2006; Gomez et al., 1995; Guo et al., 2009; X. J. Liu et al., 2007; Uberall et al., 1999). 
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PKCζ/Par6/Par3, a complex activated by Cdc42, is associated with the assembly of tight 
junctions, apical polarization of epithelial cells, and microtubule organization (Baluch & 
Capco, 2008; Etienne-Manneville & Hall, 2001; Izumi et al., 1998; A. Johansson, 
Driessens, & Aspenstrom, 2000; Lin et al., 2000; Qiu, Abo, & Steven Martin, 2000). 
PKCζ/Par6/Par3, when associated with tight junctions is located at the apical surface of 
epithelial cells (Ebnet et al., 2001). Since p120 catenin activates Cdc42, and Cdc42 
activates PKCζ, we next hypothesized that assembly of the PKCζ/Par3/Par6 complex 
associated with tight junctions might be impaired in the expanded ductal epithelium of 
homozygous p120f/f pancreata. To address this, we immunostained for PKCζ, which 
revealed an increase in cytoplasmic PKCζ in expanded ductal epithelium of CPdx1; p120f/f 
pancreata when compared to controls (Figure 2.13). Therefore, these results suggest a 
connection between increased cytoplasmic availability of the cytoskeletal remodeler 
PKCζ and the observed defects in actin cytoskeletal rearrangement associated with p120 
catenin loss. 
We next assessed basal polarity by examination of Integrin alpha 6/CD49f using 
IF. At P0, both CPdx1; p120f/f and littermate control pancreata had basal localization of 
CD49f in ductal and acinar epithelia (Figure 2.11). As another assessment of basal 
polarity, we immunostained for Laminin. Both CPdx1; p120f/f and littermate control 
pancreata had basal extracellular localization of Laminin (Figure 2.12). Taken together, 
these data suggest that basal polarity is maintained, but actin cytoskeleton organization is 
not completely intact in expanded ductal epithelium of homozygous p120f/f pancreata, an 





Figure 2.9. Developmental analysis of the p120 catenin loss-of-function phenotype. 
Hematoxylin and eosin staining at various time points during pancreatic development 
demonstrated a manifest phenotype as early as E12.5 in CPdx1; p120f/f animals. (A) p120 
catenin loss resulted in expansion of epithelial tubule lumen diameter, decreased 
ramification of branching tubules, and defects in distribution of all pancreatic cell types 
during development. Asterisks indicate dilated lumens in CPdx1; p120f/f pancreases. (B) 
CPdx1; p120f/f; mTmGTg/wt pancreatic bud explants dissected at E11.5 and placed in in vitro 
culture displayed aberrant tubulogenesis, evident as early as Day 3 of culture, suggesting 
that aberrant tubulogenesis occurred in the absence of associated inflammation. White 
boxes surround the dorsal pancreatic buds, which are displayed as higher magnification 
images. White arrows depict the ventral and dorsal pancreatic buds on Day 6/7. Scale 


























































Figure 2.12. Basement membrane Laminin was maintained in CPdx1; p120f/f 
pancreatic epithelium. A section with unusually high mosaicism for p120 catenin was 
intentionally chosen to allow comparison of Muc1 and Laminin staining in p120 catenin-
expressing and p120 catenin-deleted tissue in the same section. Yellow arrows point to a 
p120 catenin-expressing acinus and red arrows show a p120 catenin-deleted acinus. 
There was no difference in Laminin or Muc1 staining between p120 catenin-expressing 



















































































































































































































































































































p120 catenin-null pancreas retains adherens junctions during development but not in 
adulthood 
It was striking to observe that epithelial integrity remained intact during development in 
CPdx1; p120f/f pancreata. This was surprising because biochemical studies have 
demonstrated that loss of p120 catenin results in a failure to retain E-cadherin at epithelial 
cell membranes (Ireton et al., 2002). This would predict a loss of adherens junction 
integrity and compromised epithelial cell-cell adhesion. In order to examine adherens 
junction integrity, we next evaluated localization of members of the adherens junction 
complex during pancreatic development. 
p120 catenin-null pancreatic epithelia display an overall reduction in adherens 
junction components during development when compared to wild-type controls. 
However, despite the loss of p120 catenin in pancreatic epithelium, significant amounts 
of E-cadherin, β-catenin, and α-catenin remained detectable at the membrane throughout 
embryonic development as assessed by IF (Figure 2.14 A,B and data not shown). The 
reduction of adherens junction proteins at cell membranes is particularly evident in 
homozygous p120f/f animals containing mosaic tissue that display both p120 catenin-null 
and p120 catenin-expressing pancreatic epithelium in the same section (Figure 2.14 A,B).  
As an additional means to assess expression of adherens proteins, quantitative 
RT-PCR was used to compare expression of Cdh1, Ctnnb1, and Ctnna1 between wild-
type and CPdx1; p120f/f pancreata at E14.5 and E17.5. At E14.5, there is no difference in 
expression of Cdh1 or Ctnnb1, but Ctnna1 expression is significantly increased in 
homozygous p120f/f pancreata when compared to controls (Figure 2.15A). At E17.5, there 
is a very significant reduction in expression of Cdh1 and Ctnnb1 in CPdx1; p120f/f 
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pancreata when compared to wild-type and no difference in expression of Ctnna1 (Figure 
2.15B). It is worth noting that although RNA was collected from whole pancreas 
(epithelium + mesenchyme), we did not observe any difference in the amount of p120 
catenin-expressing mesenchyme in homozygous p120f/f animals vs. controls during 
pancreatic development, which allows us to attribute any differences observed in gene 
expression directly to pancreatic epithelium. Collectively, these results suggest that 
despite p120 catenin loss, there remains significant expression of Cdh1, Ctnnb1, and 
Ctnna1 in pancreatic epithelium during development.  
In contrast to the maintenance of organized adherens junctions during 
development, adult CPdx1; p120f/f pancreata do not retain E-cadherin and β-catenin at cell 
membranes in epithelial cells lacking p120 catenin (Figure 2.8C,D). These data suggest 
that there are compensatory mechanisms present during pancreatic development, but not 
in adulthood, that permit retention of adherens junctions in the absence of p120 catenin. 
Nuclear labeling of β-catenin was minimal and comparable in both wild-type and 
homozygous p120f/f pancreata, as assessed by high resolution confocal microscopy, 
suggesting that decreased localization of β-catenin to the membrane was not 
accompanied by an increase in translocalization of β-catenin to the nucleus in 
homozygous p120f/f pancreata (data not shown).  
Because p120 catenin has been shown to play a crucial role in cadherin molecule 
stability and regulation of cadherin turnover at cell membranes (Davis et al., 2003; Ireton 
et al., 2002), we next sought to understand the retention of adherens junction members in 
p120 catenin-null epithelia in vivo. We examined the expression of related p120 catenin 
family members in normal and p120 catenin-deleted pancreas by IF and qPCR. In wild-
38 
 
type pancreata, ARVCF, δ-catenin, and p0071 were localized uniformly along cell 
membranes of islet and ductal cells, and at the apical surface of some acini (Figure 
2.17A,B,C). δ-catenin was also expressed in some lateral acinar cell membranes in wild-
type pancreas (Figure 2.17B). We found that all of the p120 catenin family members 
examined were present at cell membranes in both p120 catenin-null ducts and acinar 
cells. Quantitative RT-PCR showed a significant reduction in expression of ARVCF, δ-
catenin, and p0071 in homozygous p120f/f pancreata when compared to controls (Figure 
2.17D). Retention of E-cadherin, which might be stabilized by substitution of ARVCF, δ-
catenin, and p0071 for p120 catenin, likely provides stability for the maintenance of other 
adherens junctions members and accompanying epithelial integrity during development 


















Figure 2.15. Adherens junction components are expressed in CPdx1; p120f/f epithelia 
during development. (A-B) Comparison of gene expression of Cdh1, Ctnnb1, and 
Ctnna1 between wild-type and homozygous p120f/f pancreata at E14.5 and E17.5 using 
qPCR. Note that expression of Cdh1 and Ctnnb1 was not significantly different at E14.5 
but was reduced at E17.5 in homozygous p120f/f pancreases when compared to controls. 
Wild-type control targets were normalized to 1. For all genotypes and all genes at both 
E14.5 and E17.5 time points, n=7, and reactions were run in quadruplicate. For 
interpretation of statistical results from Student’s t test, ns = not significant and p value > 
0.05, * = p value ≤ 0.05, ** = p value ≤ 0.01, *** = p value ≤ 0.001, and **** = p value 



















Figure 2.17. p120 catenin family members are expressed in homozygous p120f/f 
pancreas. Expression of ARVCF, δ-catenin, and p0071 in CPdx1; p120f/f and wild-type 
pancreases was compared using qPCR. A significant reduction in expression of ARVCF, 
δ-catenin, and p0071 was observed in homozygous p120f/f pancreases when compared to 
controls. Wild-type control targets were normalized to 1. For all genotypes and all genes, 
n=7, and reactions were run in quadruplicate. For interpretation of statistical results from 
Student’s t test, ns = not significant and p value > 0.05, * = p value ≤ 0.05, ** = p value ≤ 











The effects of conditional deletion of p120 catenin in different organ systems are highly 
variable, ranging from no observed phenotype (prostate and ureteric bud) to severe 
developmental defects (salivary gland, mammary gland, kidney, and other organs) and 
tumor formation (breast, esophagus, and other organs). We have used a mouse model of 
conditional p120 catenin deletion in epithelial pancreatic lineages to examine the role of 
p120 catenin during pancreatic development. Our data show that loss of p120 catenin 
results in overall defects in pancreatic tubulogenesis, branching morphogenesis, and 
acinar cell differentiation. We also observed differences in the abundance of specific 
pancreatic cell types and induction of inflammation within the neonatal pancreas. 
Strikingly, loss of p120 catenin induced changes in the embryonic pancreas that 
resembled ADM, a condition in the human pancreas that is present in the setting of either 
pancreatitis or early pancreatic cancer. p120 catenin functions as a regulator of innate 
anti-inflammatory responses in a growing number of tissues, which now include pancreas 
(Hu, 2012). Tissue-specific deletion of p120 catenin in both mouse skin and intestine 
resulted in endogenous recruitment of immune cells and the release of proinflammatory 
cytokines (Perez-Moreno et al., 2006; Perez-Moreno, Song, Pasolli, Williams, & Fuchs, 
2008; Smalley-Freed et al., 2010; Smalley-Freed et al., 2011). In the epidermis, the 
immune response induced by p120 loss was mediated partly by upregulation of NF-kB 
signaling (Perez-Moreno et al., 2006). We show that NF-kB is upregulated in the 




Aberrant tubulogenesis has been previously reported in a mouse model of loss of 
p120 catenin in the renal mesenchyme during glomerulogenesis (Marciano et al., 2011). 
In homozygous p120f/f animals, we observed aberrant tubulogenesis and an overall 
decrease in ramification of pancreatic branches at E12.5. The defects in branching 
morphogenesis may be a secondary effect of the extended epithelial tubule lumen 
diameter, or p120 catenin loss may have a direct effect on both branching morphogenesis 
and tubulogenesis. CPdx1; p120f/f animals also display abnormal localization of all 
epithelial pancreatic cell types during embryonic development when compared to wild-
type controls. Islets fail to migrate throughout the tissue and instead surround a central 
cluster of Vimentin+ cells. Acinar cells are peripherally located while ductal epithelium is 
mostly centrally located, but can be found throughout the tissue. Homozygous p120f/f 
pancreata also show a decrease in normal acinar cell differentiation and an expansion of 
duct-like epithelium during development. A similar result has been previously reported 
upon deletion of p120 catenin in the mouse salivary gland, which showed blocked acinar 
cell differentiation and a corresponding increase in ductal epithelium (Davis & Reynolds, 
2006). Aberrant actin cytoskeleton organization in expanded ductal epithelium of 
homozygous p120f/f pancreata was accompanied by increased cytoplasmic PKCζ, 
suggesting a connection between modulation of the actin cytoskeleton by PKCζ, 
specifically in the context of p120 catenin loss.  
A reduction of adherens junction members at cell membranes upon conditional 
ablation of p120 catenin has been reported in many developing organ systems (dental 
enamel, salivary gland, mammary gland, kidney, skin, and vasculature). Despite a 
reduction, significant retention of adherens junction components are observed in many of 
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these developing organ systems upon loss of p120 catenin. Collectively, these in vivo 
data differ from biochemical in vitro studies which have shown that loss of p120 catenin 
results in near complete loss of adherens junction components, thereby suggesting that 
compensatory mechanism(s) for stabilization of cadherin molecules in the absence of 
p120 catenin exist in vivo in some developing organ systems (Davis et al., 2003). For 
pancreas, retention of adherens junction components in the absence of p120 catenin is 
observed only during pancreatic development, and not in adults. We show that p120 
catenin family members ARVCF, δ-catenin, and p0071 are present at cell membranes 
even following p120 catenin deletion; since these family members are also capable of 
stabilizing E-cadherin, they may partially compensate for p120 catenin loss. Relevant to 
our in vivo observations, ARVCF and δ-catenin have previously been shown to rescue E-
cadherin stabilization in the absence of p120 catenin in vitro (Davis et al., 2003). 
However, to our knowledge, no in vivo studies to date have shown full functional 
redundancy for cadherin stabilization by substitution of ARVCF, δ-catenin, or p0071 for 
p120 catenin in p120 catenin-deleted tissues. Although p120 catenin family members 
might partially compensate for retention of adherens junctions with loss of p120 catenin, 
this compensation is not sufficient to guarantee normal pancreas development, and loss of 
p120 catenin results in a dramatic phenotype. Taken together, our data indicate a crucial 
role for p120 catenin in pancreatic tubulogenesis, branching morphogenesis, acinar cell 






MATERIALS AND METHODS 
Mice  
All animal studies were approved by the Animal Care and Use Committee at Johns 
Hopkins University. Mouse strains used in this study were Tg(Pdx1-cre)89.1Dam (MGI 
ID: 2684317) (G. Gu, Dubauskaite, & Melton, 2002), Ctnnd1tm1Abre (MGI ID: 3617486) 
(Davis & Reynolds, 2006), and ROSAmT/mG (MGI ID: 3716464) (Muzumdar, Tasic, 
Miyamichi, Li, & Luo, 2007). The mice were housed under a 14/10 hour light/dark cycle 
with free access to food and water.  
 
Genotyping 
Ctnnd1tm1Abre, Pdx1-cre, and ROSAmT/mG alleles were maintained by breeding 
heterozygous mice to C57BL/6J mice. Genotyping was accomplished by PCR or 
Transnetyx. Primers used to genotype for the Ctnnd1tm1Abre allele were p120 FP (5’-
TTTTAGAGCCTCCCACATACAAGC-3’) and p120 RP (5’-
TCAGCACCCACACAAAGGTTG-3’) as previously described (Davis & Reynolds, 
2006). Primers used to genotype for the Pdx1-cre allele were Pdx1-FP (5’-
GAACTGGGGAGGAAAAGGAG-3’) and Cre2-RP (5’-
GATGAAGCATGTTTAGCTGG-3’). Primers used to genotype for the ROSAmT/mG 
allele were Rosa26r FP (5’- CTCTGCTGCCTCCTGGCTTCT-3’), Rosa26r RP (5’- 
CGAGGCGGATCACAAGCAATA-3’), and mTmG RP (5’- 
TCAATGGGCGGGGGTCGTT-3’). Primers used to determine the sex of neonatal mice 
were designed to amplify the ZFX and ZFY genes as previously described (Valer Carstea 





Mouse pancreata were fixed in 10% Neutral Buffered Formalin or 4% Paraformaldehyde 
at 4°C and embedded in paraffin for sectioning. Five micron sections were prepared for 
hematoxylin and eosin staining, alcian blue staining, immunofluorescence, and 
immunohistochemistry. Primary antibodies and other immunofluorescent reagents used 
in this study are listed in Table 2.1. Secondary antibodies were used at 1:250 and were 
from Jackson ImmunoResearch.  
Embryonic tissues prepared for frozen sections were fixed in 4% 
Paraformaldehyde at 4°C, subsequently incubated in 30% sucrose at 4°C for 
cryoprotection, and embedded in OCT (Sakura Finetek 4583 CRYO-OCT Compound). 
Frozen sections were used for Phalloidin, CD49f, and Muc1 staining in Fig. 5A and α-
catenin and p120 catenin staining in Fig. 6B. A citrate-based Antigen Unmasking 
Solution from Vector Laboratories (H-3300) was used for antigen retrieval for all 
immunofluorescent staining except in OCT embedded sections. Primary antibody 
epitopes were retrieved with a heat-mediated microwave antigen retrieval method. All 
sections were blocked in 10% FBS with 0.2% Triton-X 100 in PBS. Primary antibodies 
were incubated overnight in blocking buffer at 4°C. Subsequently, secondary antibodies 
were incubated at RT for 2 hours. Immunofluorescent images were visualized on a Nikon 
A1 confocal microscope system. Histology of adult CPdx1; p120f/f males was examined by 






Antigen retrieval for Aldh1 immunohistochemistry was accomplished using Retrievit 6 
(BS-1006-00, BioGenex). For Cytokeratin 19 immunolabeling, antigen retrieval was 
done by digesting sections with 250 µg/mL proteinase K in 2.5 mmol/L CaCl2 and 
10mmol/L Tris-HCl (pH 7.5) for 6 minutes at room temperature. For NF-kB 
immunohistochemistry, antigen retrieval was accomplished using R-Buffer A (62706-10, 
Electron Microscopy Sciences). Antigen retrieval for CD45 was accomplished using a 
citrate based antigen retrieval buffer and a heat-mediated microwave method. 
Immunohistochemistry staining was visualized on an Olympus BX40 light microscope.  
 
Dissection and in vitro culturing of pancreatic bud explants 
Pregnant female mice were sacked on E11.5, and embryos were removed. Pancreatic 
anlagen including surrounding mesenchyme, caudal stomach, and proximal duodenum 
were dissected from each embryo and cultured as previously described for up to 7 days 
(Puri & Hebrok, 2007). Day 0 is defined as the day of dissection. For timed breeding, 
noon of the day when vaginal plugs were first observed was considered 0.5 days post 
conception (dpc). 
 
RNA isolation, quantitative RT-PCR, and statistical analysis 
RNA was isolated from whole mouse pancreas (epithelium + mesenchyme) at various 
stages of embryonic development and at a postnatal stage using the RNeasy Mini kit 
(Qiagen). Reverse transcription was accomplished using QuantiTect Reverse 
Transcription kit (Qiagen). Complementary DNA was amplified using a 7900HT Fast 
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Real-Time PCR System and TaqMan Gene Expression Assays (Life Technologies). 
Statistical calculations were performed using GraphPad Prism (GraphPad software) or 
Microsoft Excel (Microsoft Office 2013), and data are presented as mean ± SEM. Data 
were compared between groups using an unpaired Student’s t test. Significance was 


























Reference IF IHC 
α-Amylase 1:500  Sigma-Aldrich A8273  
α-catenin 1:700  Sigma-Aldrich C2081  
Aldh1  1:500 Abcam ab23375  






β-catenin 1:800  BD Transduction 
Laboratories 
610154  
CD45  1:1000 Abcam ab10558  
CD49f 1:200  BD Biosciences 555734  
Cleaved 
Caspase-3 
1:100  Cell Signaling 
Technology 
9664S  









DBA 1:250  Vector 
Laboratories 
RL-1032  
δ-catenin 1:600  Millipore 07-259  
Ecadherin 1:500  BD Transduction 
Laboratories 
610181  
Ecadherin 1:50  BD Pharmingen 560061  
Glucagon 1:400  Dako A0565  
Insulin 1:400  Linco 4011-01  
Ki67 1:50  Abcam ab833  
Laminin 1:50  Abcam ab11575  
Muc-1 Ab-5 1:200  Calbiochem HM-1630-
P 
 
NF-kB  1:50 Cell Signaling 
Technologies 
C22B4  
NF-kB  1:50 Abcam ab28856  




Hergt, & Franke, 
2009) 
p120 (6H11) 1:1000  Gift from Albert 
Reynolds 





p120 F1αSH 1:400  Gift from Albert 
Reynolds 
N/A (Wu et al., 1998) 
Pdx1 1:10000  Gift from Chris 
Wright 
N/A  
Phalloidin 1:100  Invitrogen A12379  
PKCζ 1:500  Santa Cruz 
Biotechnology 
sc-216  
pp120 1:400  BD Biosciences 610133  
Sox9 1:500  Millipore AB5535  
















CHAPTER 3 – P120 CATENIN SUPPRESSES BASAL EPITHELIAL CELL 
EXTRUSION IN INVASIVE PANCREATIC NEOPLASIA  
INTRODUCTION 
Genetic and epigenetic alterations in genes encoding cell adhesion molecules are 
a hallmark of many epithelial cancers. For pancreas cancer, homophilic cell adhesion has 
been categorized as one of twelve core signaling pathways (Jones et al., 2008). 
Homophilic cell adhesion in epithelial cells is mediated partly through cadherins and 
catenins in adherens junctions. Misexpression of the adherens junction protein p120 
catenin has been identified in several types of human carcinomas (van Hengel & van 
Roy, 2007). Studies have suggested variable roles for p120 catenin in the pathogenesis of 
epithelial cancers, to include tumor suppression and metastatic progression (Schackmann 
et al., 2013; Stairs et al., 2011). In human pancreatic cancer, misexpression of p120 
catenin in primary tumors is significantly correlated with vascular invasion, metastasis, 
differentiation, pTNM stage, and poor survival (Fei et al., 2009; Mann et al., 2012; 
Mayerle et al., 2003). Reduction and cytoplasmic relocalization of p120 catenin has also 
been reported in 100% of solid pseudopapillary tumors of the pancreas (Chetty, Jain, & 
Serra, 2008). A study using a forward genetic screen in mice identified Ctnnd1 as a 
“candidate cancer gene” in Kras-driven pancreatic neoplasia (Mann et al., 2012). These 
data suggest that disruption of CTNND1 in pancreatic tumors has biological relevance to 
disease, yet, the mechanisms by which p120 catenin contributes to the development and 
progression of pancreatic cancer are not understood.  
Increased occurrence of metastasis with altered p120 catenin expression suggests 
that p120 catenin may play a role in metastatic progression of pancreatic cancer. A 
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mechanism recently hypothesized to initiate metastasis by mediating invasion is basal 
epithelial cell extrusion (Y. Gu et al., 2015; G. M. Slattum & Rosenblatt, 2014). 
Epithelial tissues maintain homeostatic cell numbers by extruding cells through a highly 
conserved mechanism involving production and secretion of the signaling lipid 
sphingosine 1-phosphate (S1P). Extracellular S1P binds to S1P receptor 2 (S1pr2) on 
neighboring cells, which induces contraction of an actomyosin band that extrudes the cell 
out of the epithelium while preserving barrier function (Andrade & Rosenblatt, 2011; 
Eisenhoffer et al., 2012; Eisenhoffer & Rosenblatt, 2013; Y. Gu, Forostyan, Sabbadini, & 
Rosenblatt, 2011; Y. Gu & Rosenblatt, 2012; Rosenblatt, Raff, & Cramer, 2001; G. 
Slattum, McGee, & Rosenblatt, 2009). Mutations in the tumor suppressor APC and 
oncogenic Kras have been shown to shift the predominant direction of epithelial cell 
extrusion from apical to basal, where extruded cells invade the underlying epithelium and 
survive (Marshall, Lloyd, Delalande, Nathke, & Rosenblatt, 2011; G. Slattum, Gu, 
Sabbadini, & Rosenblatt, 2014). The results presented in this study show that p120 
catenin restrains epithelial cell extrusion in the earliest stages of pancreatic neoplastic 










p120 catenin is misexpressed in human premalignant and malignant pancreatic lesions  
Expression and localization of p120 catenin, a critical cytoskeletal regulator and 
component of adherens junctions, were rated in human normal pancreas, chronic 
pancreatitis, acinar to ductal metaplasia (ADM), pancreatic intraepithelial neoplasia 
(PanIN) 1-3, and primary tumors and metastases. Examples of scores in each category are 
presented in Figure 3.1. p120 catenin is expressed in all normal pancreatic cell types 
(Figure 3.2A,B). Localization of p120 catenin was scored as predominantly membranous 
in 100% of normal pancreatic cell types (n=22-33 patients for each pancreatic cell type) 
(Figure 3.3D). Punctate cytoplasmic and nuclear staining were also observed in normal 
pancreatic cells (Figure 3.2A,B). p120 catenin expression was rated as high in >91% 
chronic pancreatitis and ADM (n=25/26 chronic pancreatitis, n=23/25 ADM) (Figure 
3.2C,I). Expression levels of p120 catenin were significantly decreased in primary tumors 
when compared to PanIN lesions (n=31 PanIN and n=16 primary tumors, P=0.0005) 
(Figures 3.2D-F, 3.3A,C). Moreover, p120 catenin expression was significantly lower in 
metastases when compared to primary tumors (n=16 primary tumors and n=16 
metastasis) (P=0.0361) (Figure 3.3A-C). There was also a significant difference in 
predominant p120 catenin subcellular localization when comparing PanIN1-2 and 
PanIN3 (n=26 PanIN1-2 and n=5 PanIN3, P=0.0082) (Figure 3.3D). Together, these 
findings demonstrate that altered p120 catenin expression and localization is a 







               
Figure 3.2. Expression of p120 catenin in human pancreas. A,B) 
Immunohistochemistry (IHC) shows high p120 catenin expression in normal acinar and 
duct cells and medium p120 catenin expression in normal islets. Immunofluorescence 
(IF) labeling showing p120 catenin overlaid with CK19 and Dapi allowed visualization of 
punctate cytoplasmic and nuclear p120 catenin in normal pancreatic cells. C-E) 
Pancreatitis, ADM, and PanIN1-2 lesions depicted show predominant membranous and 
high p120 catenin expression. F) PanIN3 depicted shows predominant cytoplasmic and 


























































Pancreatic loss of p120 catenin in the context of oncogenic Kras results in accelerated 
PanIN progression 
Previously, using CPdx1; p120f/f mice, we reported that p120 catenin is required for proper 
tubulogenesis and cell-type specification during pancreas development (Hendley et al., 
2015). To determine the function of p120 catenin in adult mouse pancreas in the absence 
of a confounding developmental phenotype, we crossed transgenic mice harboring floxed 
alleles of p120 catenin (p120f) (Davis & Reynolds, 2006) with Mist1CreER/+ (CiMist1) mice 
(Habbe et al., 2008). p120f/f, CiMist1; p120wt/wt, CiMist1; p120f/wt, and CiMist1; p120f/f mice 
displayed normal pancreatic histology 2-4 months post tamoxifen injection (Figure 3.4A-
C). Similar to what we previously reported for CPdx1; p120f/f mice 10 months of age 
(Hendley et al., 2015), a subset of CiMist1; p120f/f mice 12 months post tamoxifen injection 
exhibited pancreatitis and ADM (Figure 3.4D).  
Since we observed mislocalized p120 catenin in human PanIN, before the onset of 
pancreatic cancer, we next sought to determine if p120 catenin plays a functional role in 
PanIN formation and progression. To this end, we crossed CiMist1; p120f/f mice with lox-
stop-lox-KrasG12D (K) mice (Hingorani et al., 2003), which resulted in simultaneous 
ablation of p120 catenin and activation of oncogenic KrasG12D in adult pancreatic acinar 
cells upon tamoxifen administration (Figure 3.5A). The KCiMist1 mouse model displays 
the full spectrum of murine preinvasive ADM and PanIN1-3 lesions in a manner that 
faithfully recapitulates human preinvasive pancreatic lesions (Habbe et al., 2008). We 
performed survival analysis on cohorts of KCiMist1; p120wt/wt, KCiMist1; p120f/wt, and 
KCiMist1; p120f/f mice, which showed significant differences in overall survival (Figure 
3.5B). KCiMist1; p120f/f mice exhibited cachexia, which is also frequently observed in 
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human pancreatic cancer patients (Figure 3.5C,D). The gross appearance of KCiMist1; 
p120f/f pancreata was strikingly abnormal and enlarged when compared to KCiMist1; 
p120wt/wt pancreata (Figure 3.5E-G). 
Histologically, KCiMist1; p120wt/wt, KCiMist1; p120f/wt, and KCiMist1; p120f/f pancreata 
are comparable at 1 week post tamoxifen injection (Figure 3.6A,A’). At 2 weeks post 
tamoxifen injection, KCiMist1; p120f/f pancreata show significantly accelerated ADM 
formation and increased recruitment of a fibroinflammatory infiltrate when compared to 
KCiMist1; p120wt/wt and KCiMist1; p120f/wt pancreata (Figure 3.6B,B’). One month post 
tamoxifen injection, KCiMist1; p120f/f pancreata display significantly increased fibrostroma 
(92.89% ± 0.66% pancreatic area, n=6 mice) when compared to KCiMist1; p120f/wt 
pancreata (0.14% ± 0.03% pancreatic area, n=4 mice) (P=<0.0001) and KCiMist1; p120wt/wt 
pancreata (0.31% ± 0.21% pancreatic area, n=6 mice) (P=<0.0001). Significant increases 
in low and high grade PanIN formation were observed in KCiMist1; p120f/f pancreata when 












Figure 3.4. CiMist1; p120f/f pancreata show ADM and pancreatitis. A-D) p120f/f, CiMist1; 
p120wt/wt, and CiMist1; p120f/wt pancreata displayed normal histology, and IHC showed 
p120 catenin expression at 2-4 months of age. E) CiMist1; p120f/f pancreata 4 months of 
age showed normal histology and lack p120 catenin expression in acinar cells. CiMist1; 
p120f/f pancreata 12 months of age developed ADM and pancreatitis (n=1/3 mice). Note 
that the 12 month image contains unusually high mosaic p120 catenin expression in 
acinar cells, but ADM lack p120 catenin expression, suggesting that these lesions may be 
forming in a cell autonomous manner. We stained for Alcian blue to suggest the presence 





































































KCiMist1; p120f/f pancreata show a prominent acute and chronic inflammatory response  
As expected, p120 catenin was ubiquitously expressed in KCiMist1; p120wt/wt and KCiMist1; 
p120f/wt pancreata (Figure 3.8A,B). Minimal mosaic expression of p120 catenin was 
observed in KCiMist1; p120f/f pancreatic acini (Figure 3.8C). KCiMist1; p120f/f pancreata 
displayed marked acinar cell atrophy, pronounced inflammation, and contained stroma 
characterized by a unique cellular constitution that differs from the stroma in KCiMist1; 
p120wt/wt pancreata (Figure 3.8D-L). KCiMist1; p120f/f pancreata displayed less mucinous 
lesions than KCiMist1; p120wt/wt and KCiMist1; p120f/wt pancreata, as manifested by Alcian 
blue staining (Figure 3.9A-C). KCiMist1; p120f/f pancreata also showed areas of ductal 
dilation (Figure 3.10A-C). Disruption of contiguous basement membrane Laminin 
expression, a characteristic of human pancreatic cancer (Pan et al., 2009), was also seen 
in KCiMist1; p120f/f pancreatic lesions. This was accompanied by cells that escaped intact 















                                    
Figure 3.9. Alcian blue staining suggests PanIN formation in KCiMist1; p120wt/wt, 
KCiMist1; p120f/wt, and KCiMist1; p120f/f pancreata. Alcian blue staining showed the 
presence of PanIN lesions in KCiMist1; p120wt/wt, KCiMist1; p120f/wt, and KCiMist1; p120f/f 






























Figure 3.10. Basement membrane Laminin is disrupted in KCiMist1; p120f/f pancreata. 
A-C) KCiMist1; p120f/f pancreata displayed notable dilated ducts, which were not seen in 
KCiMist1; p120wt/wt and KCiMist1; p120f/wt pancreata. D-F) PanIN in KCiMist1; p120wt/wt and 
KCiMist1; p120f/wt pancreata showed very little basement membrane Laminin expression. 
Orange arrows point to regions in which contiguous basement membrane Laminin 
expression was disrupted in KCiMist1; p120f/f pancreata. Single cells expressing Laminin 























Lineage tracing reveals that loss of p120 catenin in cooperation with oncogenic Kras 
promotes striking cell extrusion 
The exit of epithelial cells across the basement membrane of discernable epithelial 
structures, a process termed delamination, occurs in KPCPdx1Y and KCiMist1Y PanIN mice 
and has been associated with EMT (Rhim et al., 2012). Since loss of p120 catenin in 
pancreatic cancer cell lines results in increased migration and invasion, also associated 
with EMT (Hamada et al., 2013), we next sought to determine if p120 catenin regulated 
delamination in PanIN mice. First, we examined expression of p120 catenin and E-
cadherin in delaminated cells in 2 lineage-traced murine models of PanIN: KPCPtf1aY and 
KCiMist1G (Bailey et al., 2014; McAllister et al., 2014). Delaminated cells in KPCPtf1aY 
PanIN mice expressed decreased adherens junction proteins p120 catenin and E-cadherin 
when compared to their surrounding pancreatic epithelia (Figure 3.11A). KCiMist1G; 
p120wt/wt PanIN mice showed decreased p120 catenin and E-cadherin expression in non-
epithelial delaminated cells, some of which have an elongated fibroblast cell morphology 
(Figure 3.11B). These data show that decreased expression of adherens junction proteins 
p120 catenin and E-cadherin is a manifest feature of delaminated cells in PanIN mice. 
 To further investigate the role of p120 catenin in delamination in Kras-induced 
premalignant pancreatic neoplasia, we next examined delaminated cells in lineage-traced 
KCiMist1G; p120f/wt and KCiMist1G; p120f/f mice. Monoallelic and biallelic loss of p120 
catenin resulted in remarkable abundant delamination of GFP+ cells that retained E-
cadherin (Figure 3.11C,D). Both delamination, also termed basal epithelial cell extrusion 
(Y. Gu & Rosenblatt, 2012), as well as apical epithelial cell extrusion were significantly 
increased in KCiMist1; p120f/wt and KCiMist1; p120f/f pancreata when compared to KCiMist1; 
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p120wt/wt pancreata (Figure 3.12A-E). Abundant apical and basal epithelial cell extrusion 
was 100% penetrant in KCiMist1; p120f/wt and KCiMist1; p120f/f pancreata, with the 
phenotype evident in KCiMist1; p120f/f pancreata by 2 weeks post tamoxifen injection 
(Figure 3.13A). Quantification of extruded isolated CK19+ cells revealed 838/7000 in 
KCiMist1; p120f/f pancreata, 76/7000 in KCiMist1; p120f/wt pancreata, and 19/7000 in 
KCiMist1; p120wt/wt pancreata (Figure 3.13B). Lineage tracing in KCiMist1; p120f/f pancreata 
showed extruded GFP+, CK19+ single cells were negative for Vimentin, a marker of 
mesenchymal differentiation and EMT (Figure 3.13C). These data show that p120 
catenin suppresses epithelial cell extrusion in Kras-driven pancreatic neoplasia. In 
addition, these data show that p120 catenin is not required for maintenance of either E-
cadherin localization to cell membranes or epithelial cell identity after basal epithelial 
cell extrusion in the context of oncogenic Kras. Furthermore, basal epithelial cell 



















p120 catenin loss in the context of cerulean-induced pancreatitis promotes epithelial cell 
extrusion 
Biallelic loss of p120 catenin during pancreas development promotes apical epithelial cell 
extrusion (Hendley et al., 2015). Luminal cell extrusion has also been reported with loss 
of p120 catenin in developing kidney and MDCK cysts (Marciano et al., 2011). Given the 
abundant basal and apical epithelial cell extrusion observed with p120 catenin loss in 
cooperation with oncogenic Kras in premalignant pancreatic neoplasia, we next sought to 
interrogate the extrusion behavior of adult pancreatic cells in regenerating pancreas. To 
this end, acute pancreatitis was induced in CiMist1; p120wt/wt, CiMist1; p120f/wt, and CiMist1; 
p120f/f mice (Figure 3.14A). CiMist1; p120f/f pancreata showed significantly increased 
susceptibility to injury when compared to CiMist1; p120wt/wt and CiMist1; p120f/wt pancreata 
(Figures 3.16 and 3.17). Quantification of apical epithelial cell extrusion revealed a 
significant increase in CiMist1; p120f/f pancreata when compared to CiMist1; p120wt/wt and 
CiMist1; p120f/wt pancreata (Figure 3.14B,C). In addition, CiMist1; p120f/f and CiMist1; p120f/wt 
pancreata showed significantly increased basal epithelial cell extrusion when compared to 
CiMist1; p120wt/wt pancreata (Figure 3.15A,B). These data suggest that p120 catenin 
regulates both apical and basal epithelial cell extrusion in adult mouse pancreas in the 















Epithelial cells that extrude basally in KCiMist1; p120wt/wt, KCiMist1; p120f/wt, and KCiMist1; 
p120f/f pancreata survive  
We next sought to determine the fate of both apically and basally extruded epithelial cells 
in KCiMist1; p120wt/wt, KCiMist1; p120f/wt, and KCiMist1; p120f/f pancreata. Since epithelial 
cells can extrude apically by a mechanism involving S1P/S1pr2 signaling and activation 
of cleaved Caspase-3 (Y. Gu et al., 2011; Rosenblatt et al., 2001), we next examined 
cleaved Caspase-3 expression in extruded CK19+ cells. Consistent with this previously 
reported mechanism of apical cell extrusion, we observed cleaved Caspase-3 expression 
in apically extruded CK19+ cells in KCiMist1; p120wt/wt, KCiMist1; p120f/wt, and KCiMist1; 
p120f/f pancreata (Figure 3.18A-C). However, we observed no cleaved Caspase-3 
expression in isolated, basally extruded CK19+ cells, suggesting that basally extruded 
CK19+ cells exit intact pancreatic epithelial structures and remain viable (Figure 3.18A-
C).  
 
Basally extruded isolated epithelial cells in KCiMist1; p120f/f pancreata display aneuploidy 
and nuclear enlargement 
Because we observed prominent nucleoli and nuclear enlargement of basally extruded 
epithelial cells in KCiMist1; p120f/f pancreata, we next analyzed the DNA content of 
isolated CK19+ cells in KCiMist1; p120f/f pancreata using OTMIAS Image Analysis 
Software on Feulgen stained slides (Figure 3.19A-C). A population of pancreatic cells 
was observed with a DNA index of 1.5, which was indicative of aneuploidy (Figure 
3.19C). In addition, 8.3% (21/253) pancreatic cells analyzed showed abnormal DNA 
content with a DNA index of ≥ 2.5 (Figure 3.19C). The histology of KCiMist1; p120f/f 
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pancreata thus comprises a very unique phenotype with overall benign neoplasia and 
reactive stroma containing isolated epithelial cells that display features of malignancy 
including enlarged, hyperchromatic and pleomorphic nuclei, prominent nucleoli, 
aneuploidy and occasional binuclear cells. These findings suggest that p120 catenin loss 
in the context of oncogenic Kras promotes formation of invasive pancreatic neoplasia 
(Figure 3.19D).  
 
Isolated epithelial cells in human PDAC misexpress p120 catenin 
As we identified that loss of p120 catenin in cooperation with oncogenic Kras promotes 
invasion of epithelial cells displaying characteristics of malignancy in pancreatic 
neoplasia, we next examined expression of p120 catenin in isolated epithelial cells in 
human PDAC. Single malignant epithelial cells in human PDAC are depicted in Figure 
3.20A,B. Quantification of p120 catenin subcellular localization in 253 isolated epithelial 
cells from 17 patients with PDAC showed a sparse 4.74% of cells with normal membrane 
labeling and 95.26% of cells with predominant cytoplasmic or absent p120 catenin 
localization (Figure 3.20C,D). These data show that altered p120 catenin subcellular 














KCiMist1; p120f/f pancreata display a unique transcriptome signature and a downregulated 
S1P biosynthetic pathway  
As a means to identify the mechanisms by which p120 catenin ablation in cooperation 
with oncogenic Kras promotes epithelial cell extrusion, we performed whole 
transcriptome analysis on fluorescence activated cell sorted (FACS) GFP+ pancreatic 
cells in KCiMist1G; p120wt/wt and KCiMist1G; p120f/f mice 2 weeks post tamoxifen injection 
(Figure 3.21A). IPA analysis showed 56 statistically significant differentially expressed 
pathways, several of which are related to actin cytoskeleton signaling, the inflammatory 
response, and cell adhesion and migration (Figure 3.21B). Cytoplasmic p120 catenin 
regulates Rho family GTPases by inhibiting RhoA and activating Rac1 and Cdc42, which 
together modulate cytoskeleton organization and cell migration (Noren et al., 2000). 
Previously, we showed that actin cytoskeleton organization was disrupted in CPdx1; p120f/f 
pancreata, and that this observation was associated with increased cytoplasmic PKC, a 
known modulator of actin cytoskeleton dynamics (Hendley et al., 2015). Here, we 
similarly find that KCiMist1; p120f/f pancreata show increased cytoplasmic PKC when 
compared to KCiMist1; p120f/wt and KCiMist1; p120wt/wt pancreata (Figure 3.22A-C). 
Expression of adherens junction components E-cadherin and β-catenin was also reduced 
in KCiMist1; p120f/f pancreata (Figure 3.22D-I). In addition, IHC confirmed intrinsic 
activation of NF-kB in KCiMist1; p120f/f pancreata (Figure 3.22J-L).  
Since defective S1P/S1pr2 mediated cell extrusion in the context of mutant Kras 
has been shown to shift the predominant direction of cell extrusion from apical to basal 
(G. Slattum et al., 2014), we next queried whether p120 catenin regulated S1P/S1pr2 
signaling. We performed qPCR on FACS-sorted GFP+ pancreatic cells in KCiMist1G; 
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p120wt/wt and KCiMist1G; p120f/f mice at 1 month post tamoxifen injection (Figure 3.23A). 
We found an overall decrease in expression of genes mediating S1P/S1pr2 signaling 
(Figure 3.23A). The expression of genes involved in the biosynthetic pathway of S1P, 
Sphk1 and Sphk2, was significantly decreased -5.83 fold and -3.96 fold, respectively, 
suggesting that p120 catenin regulates biosynthesis of S1P in a mutant Kras-dependent 
context. We next investigated the relationship between p120 catenin loss and epithelial 
cell extrusion mediated by S1P/S1pr2 signaling using an epithelial, Kras mutant, human 
pancreatic cancer cell line. CFPAC-1 cells express both p120 catenin and S1pr2 and form 
spheres (CFPAC-1 spheres) that can extrude cells basally when grown in Matrigel 
(Figure 3.23B,C). The percentage of CFPAC-1 spheres extruding epithelial cells basally 
increased significantly following p120 catenin knockdown (Figure 3.23D). Furthermore, 
the specific S1pr2 agonist CYM-5520 (Satsu et al., 2013) significantly decreased the 
frequency of basal extrusion in p120 catenin-deficient spheres to levels similar to those 
observed in p120 catenin-expressing spheres (Figure 3.23D). No significant difference 
was observed between extruded live and dead single cells in any treatment condition 
(data not shown). The ability of restored S1P/S1pr2 signaling to rescue the p120 catenin 
loss of function phenotype indicates a direct mechanism by which p120 catenin loss 














The critical role of the cell-cell adhesion apparatus during tumorigenesis of epithelial 
cancers is firmly established (Cavallaro & Christofori, 2004; Jones et al., 2008). The 
association of p120 catenin with E-cadherin at epithelial cell membranes is crucial for 
formation and maintenance of adherens junctions (Ishiyama et al., 2010). p120 catenin 
loss or mislocalization can destabilize E-cadherin and affect the adhesive repertoire of the 
cell and its signal transduction status. In KCiMist1; p120f/f mice, simultaneous p120 catenin 
and E-cadherin loss likely destabilizes cell adhesion and promotes migration and 
invasion.    
Studies have shown that p120 catenin can function as a bona fide tumor 
suppressor in murine oral cavity, esophagus, and forestomach (Stairs et al., 2011). In 
contrast, targeted knockout of p120 catenin in murine salivary gland (Davis & Reynolds, 
2006), intestine (Perez-Moreno et al., 2006; Smalley-Freed et al., 2011), brain (Elia, 
Yamamoto, Zang, & Reichardt, 2006), mammary gland (Kurley et al., 2012), kidney 
(Marciano et al., 2011), eye (Tian, Sanders, Reynolds, van Roy, & van Hengel, 2012), 
epidermis (Perez-Moreno et al., 2006; Perez-Moreno et al., 2008), and lung (Chignalia et 
al., 2015) is not sufficient to promote formation of cancer. It is therefore likely that the 
requirement for p120 catenin in development and progression of cancer is tissue-specific. 
For pancreas, ablation of p120 catenin in pancreatic progenitor cells in CPdx1; p120f/f mice 
(Hendley et al., 2015) and somatic knockout of p120 catenin in adult pancreatic acinar 
cells in CiMist1; p120f/f mice does not result in development of pancreatic cancer, so 
evidence for a bona fide tumor suppressor role for p120 catenin in pancreas is lacking. 
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 The inflammation suppression function of p120 catenin is well documented (Hu, 
2012). Pancreatic loss of p120 catenin generates a microenvironment disposed to chronic 
inflammation, which may explain in part, the significant increase in ADM and PanIN 
formation in KCiMist1; p120f/f pancreata when compared to KCiMist1; p120wt/wt pancreata. 
Cerulein-induced pancreatitis in mice promotes significant increases in ADM and PanIN 
formation (Guerra et al., 2007; McAllister et al., 2014). Furthermore, dexamethasone, 
which has anti-inflammatory and immunosuppressant effects, has been shown to reduce 
ADM and PanIN formation in mice (Rhim et al., 2012), suggesting a potential link 
between inflammation and premalignant lesion formation.  
 We show loss of p120 catenin in delaminated cells associated with EMT and non-
EMT in PanIN mice. While loss of p120 catenin precedes non-EMT associated 
delamination in KCiMist1G; p120f/f pancreata, it is unclear if loss of p120 catenin precedes 
or occurs after delamination associated with EMT in KPCPtf1aY and KCiMist1G; p120wt/wt 
pancreata. Actin cytoskeleton remodeling events are necessary for EMT, and loss of 
cytoplasmic p120 catenin before occurrence of delamination may prevent cytoskeletal 
restructuring required for delamination associated with EMT. Biallelic loss of p120 
catenin in PanIN mice results in significant downregulation of genes mediating S1P 
biosynthesis, and activation of S1pr2 in vitro completely rescues increased basal 
epithelial cell extrusion seen with p120 catenin loss. These data suggest that p120 catenin 
loss in the context of oncogenic Kras may promote neoplastic epithelial cell invasion in 
part by altering S1P/S1pr2 signaling. Together, altered cytoskeletal organization, 
decreased cell adhesion, and faulty S1P/S1pr2 signaling may contribute to increased 
basally extruded epithelial cells (Figure 3.24).  
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 Few mechanisms for non-EMT associated delamination are described, yet the 
evidence that EMT is not absolutely required for invasion, dissemination, and metastasis 
is emerging (X. Liu, Huang, Remmers, & Hollingsworth, 2014; Shamir et al., 2014; 
Tsuji, Ibaragi, & Hu, 2009). In summary, we have created a model in which cooperating 
genetic insults have unraveled a new mechanism for neoplastic epithelial cell invasion in 
premalignant pancreatic cancer. The evidence that p120 catenin regulates epithelial cell 
extrusion is compelling, as p120 catenin loss affects this biologic process in injured, 
regenerating, and neoplastic pancreata. Further studies are needed to clarify the 
metastatic potential associated with monoallelic and biallelic p120 catenin loss in 















MATERIALS AND METHODS 
Human pancreatic tissue microarrays 
For expression analysis, a labeling score of 0-2 corresponding to absent/low, medium, 
and high was assigned using immunohistochemistry (IHC), and immunofluorescence (IF) 
staining or IHC was scored for predominant subcellular localization analysis all using 
human tissue microarrays (TMAs). p120 catenin expression level and predominant 
subcellular localization were each scored by 3 independent observers blinded to lesion 
classification. Importantly, each TMA contained normal human pancreatic tissue as a 
control. IF images were maximum intensity projections of Z-stacks taken using high 
resolution confocal microscopy allowing visualization of membranous, cytoplasmic, and 
nuclear labeling. In this study, predominant is defined as greater than or equal to 60% of 
the representative staining pattern or expression level. Human pancreatic pathologies 
were classified by a pathologist using H&E stained sections, either serial or exact same 
section that was scored.  
 
Mice  
Transgenic mouse strains Mist1CreER/+ (CiMist1) (Habbe et al., 2008), Ctnnd1tm1Abre (p120f) 
(Davis & Reynolds, 2006), and lox-stop-lox; KrasG12D (K) (Hingorani et al., 2003) have 
been previously described. To perform lineage tracing, we introduced the Rosa26mTmG 
(G) (Muzumdar et al., 2007) double fluorescent reporter allele into KCiMist1; p120wt/wt, 
KCiMist1; p120f/wt, and KCiMist1; p120f/f lines. Transgenic strains Ptf1atm1(cre)Wri (CPtf1a) 
(Kawaguchi et al., 2002), lox-stop-lox; KrasG12D (K) (Hingorani et al., 2003), p53LoxP 
(P) (Donehower et al., 1992), and R26R-YFP (Y) (Srinivas et al., 2001) were used to 
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generate KPCPtf1aY mice. KPCPtf1aY mice were maintained on a mixed genetic 
background, and CiMist1, p120f, K, and G mice were maintained on a C57BL/6J 
background. For experiments involving KCiMist1mice, all mice were injected at 7-9 weeks 
of age subcutaneously with 5mg tamoxifen (Sigma, T5648) once per day for 3 
consecutive days to induce Cre recombination. For studies involving mice harboring 
lineaged traced PanIN lesions, KPCPtf1aY mice were sacrificed between 6 and 8 weeks of 
age. Experimental pancreatitis was elicited as previously described (Siveke et al., 2008). 
Mice were genotyped by PCR or Transnetyx. All pancreatic pathologies in transgenic 
mice were evaluated by a pathologist. All animal studies were approved by the Animal 
Care and Use Committee at Johns Hopkins University and University of Texas Health 
Science Center at Houston. 
 
Histology/immunostaining  
Tissues were fixed in either 10% neutral buffered formalin or 4% paraformaldehyde at 
4°C, processed according to standard protocols, and embedded in paraffin for sectioning. 
5 micron sections were prepared for H&E staining, IHC, and IF. Antigen retrieval was 
performed for all antibodies using heat-mediated microwave antigen retrieval and a 
citrate-based, antigen unmasking solution from Vector Laboratories (H-3300) except rat 
anti-CD45 (Abcam, ab185744). For rat-anti-CD45, Retrievit 6 antigen retrieval solution 
was used (BioGenex, BS-1006-00). All sections were blocked in 10% FBS in PBST and 
primary antibodies were incubated overnight at 4°C. Secondary antibodies, from Jackson 
Immunoresearch, were used at 1:250 and incubated at room temperature for 2 hours. For 
IF, slides were stained with IHC-Tek Dapi counterstain solution (IHC World, IW-1404) 
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and mounted in fluorescence mounting medium (Dako, S3023). Immunofluorescent 
tissues were visualized on a Nikon A1R confocal microscope system. For IHC, slides 
were developed using Vectastain Elite ABC kit (Vector Laboratories, PK-6100) and 
DAB Peroxidase (HRP) Substrate kit (Vector Laboratories, SK-4100) and counterstained 
with hematoxylin. Primary antibodies used in this study: rabbit anti-α-Amylase (Abcam, 
ab125230, 1:500), mouse anti-β-catenin (BD Transduction Laboratories, 610154, 1:800), 
rabbit anti-cleaved Caspase-3 (Cell Signaling Technology, 9664S, 1:200), mouse anti-
Cytokeratin 19 (MyBioSource, MBS850502, 1:200), rat anti-CD45 (Abcam, ab185744, 
1:250), rat anti-Cytokeratin 19 (Developmental Studies Hybridoma Bank, Troma-III, 
1:100), rabbit anti-Cytokeratin 19 (Epitomics, AC-0073, 1:300), mouse anti-E-cadherin 
(BD Transduction Laboratories, 610181, 1:500), chicken anti-GFP (Abcam, ab13970, 
1:250), rabbit anti-Laminin (Abcam, ab11575, 1:200), rabbit anti-NF-κB p65 (phospho 
S536) (Abcam, ab28856, 1:50), rabbit anti-p120 Catenin (Genetex, GTX62350, 1:200), 
rabbit anti-p120 Catenin (Spring Bioscience, M3630, 1:100), rabbit anti-PKC (Santa 
Cruz, sc-216, 1:500), mouse anti-pp120 (BD Biosciences, 610133, 1:400), and chicken 
anti-Vimentin (Millipore, AB5733, 1:400).  
 
Premalignant lesion quantification  
ADM, PanIN1, PanIN2/3, and fibrostroma were quantified using morphometric analysis 
on hematoxylin and eosin (H&E) scanned slides in ImageJ. 2 sections per animal 
sampled at least 400µm apart were analyzed. Quantification of pancreatic area excluded 





For quantification of CK19+ basal cell extrusion, CK19+ cells (excluding apically 
extruded CK19+ cells and normal pancreatic ducts) were counted in 1 scanned section per 
animal. For quantification of CK19+ apical cell extrusion, CK19+ cells that comprised a 
luminal pancreatic epithelial structure (lumen sized at least twice the diameter of a cell 
comprising the epithelial structure and excluding normal ducts) and its associated 
apically extruded CK19+ cells were counted. 1 scanned section per animal was analyzed 
for apical extrusion quantification. Slides were scanned using an Aperio ScanScope AT.  
 
Quantification of cerulean-induced pancreatic injury 
Pancreatic injury, defined as area containing metaplastic duct lesions and/or 
inflammation, was quantified in 1 scanned H&E stained section per animal using 
morphometric analysis in ImageJ. Quantification of pancreatic area excluded lymph 
nodes. Slides were scanned using an Aperio ScanScope AT.  
 
DNA ploidy analysis 
DNA ploidy cell cycle analysis of basally extruded single epithelial cells on 4µm thick 
Feulgen-stained sections was accomplished using OTMIAS Version 2.0 Image Analysis 
Software by Olive Tree Media, LLC. Serial sections stained by CK19 IHC were used for 
identification of isolated, basally extruded epithelial cells in Feulgen stained sections. 
The internal reference control and isolated epithelial cells analyzed were located on the 
same Feulgen stained section. An aneuploid peak is defined as any distinct peak with a 
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DNA index > 1.25. Abnormal DNA content is defined as any aneuploid peak or any peak 
≥5C.  
 
RNA isolation, microarray, and qPCR 
Adult pancreatic cells were dissociated as previously described (Alsina, Leach, & Bailey, 
2013). RNA was isolated from sorted GFP+ cells using Arcterus PicoPure RNA isolation 
kit and gene expression was analyzed using Mouse exon microarray 1.0 ST (Affymetrix). 
For qPCR experiments, reverse transcription was accomplished using QuantiTect reverse 
transcription kit (Qiagen, 205311). Complementary DNA was amplified using TaqMan 
gene expression assays (Life Technologies) and the Roche LightCycler 480 system. 
Expression levels were normalized against mouse GAPDH.  
 
Western blotting 
CFPAC-1 cell extracts were prepared according to standard protocols using cell lysis 
buffer (Cell Signaling Technology, 9803S) with protease inhibitor cocktail tablets 
(Roche, 4693159001) and 100 mM PMSF. Membranes were incubated overnight with 
anti-pp120 (BD Biosciences, 610133, 1:500) and anti-EDG-5 (antibodies-online, 
ABIN317633, 1:1000). GAPDH (Cell Signaling Technology, 5174S, 1:5000) was used as 
an internal control. After incubation with the respective HRP-conjugated secondary 
antibody at RT for 1 hour, membranes were developed using either the SuperSignal West 
Pico Chemiluminescent Substrate (Thermo scientific, 34080) or the SuperSignal West 





CFPAC-1 cells were cultured in Dulbecco’s minimum essential medium (DMEM), low 
glucose, GlutaMAX™ Supplement (Life Technologies, 10567-022) supplemented with 
10% FBS (Sigma-Aldrich, F4135-500ML) and 1X penicillin-streptomycin-glutamine 
(Fisher Scientific, 10378-016) at 5% CO2, 37°C. For culturing CFPAC-1 cells in 
Matrigel, a single cell suspension of CFPAC-1 cells was resuspended in 4% Matrigel 
(BD Biosciences, 356234) at a final concentration of 6 x 104 cells/mL. 300µL cells per 
well was placed in 24 well glass bottom plates (In Vitro Scientific, P24-1.5H-N) coated 
with a thin polymerized layer of Matrigel. For immunostaining, cells were fixed in 4% 
paraformaldehyde in PBS at 37°C for 20 minutes, permeabilized for 10 minutes with 
0.2% Triton X-100, blocked with 10% FBS in PBST for 30 minutes, and incubated with 
primary antibodies mouse anti-pp120 (BD Biosciences, 610133, 1:400) and rabbit anti-
cleaved Caspase-3 (Cell Signaling Technology, 9664S, 1:100) diluted in blocking buffer 
for 2 hours. Subsequently, cells were incubated with secondary antibodies (Jackson 
Immunoresearch) diluted in blocking buffer at RT for 2 hours. Dapi was used for nuclear 
staining and cells were mounted in fluorescence mounting medium (Dako, S3023). 




CFPAC-1 cells grown in Matrigel formed spheres by Day 2 and were transfected on Day 
2 using lipofectamine RNAiMAX (Invitrogen, 56532). The final concentration of siRNA 
used per well was 5pmol. siRNA against p120 catenin and control siRNA were obtained 
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from Santa Cruz (sc-36139 and sc-37007, respectively). For S1pr2 agonist experiments, 
cells were treated with 10µM CYM-5520 (Sigma, SML1014-25MG) on Day 4, 48 hours 
after transfection. CFPAC-1 spheres were fixed on Day 6, 96 hours after transfection, for 
analysis. Day 0 is defined as the day of plating the cells in Matrigel.  
  
Accession number 
The Gene Expression Omnibus accession number for the microarray analysis reported in 
this paper is GSE68090.  
 
Statistical analysis 
Data are presented as mean ± SEM and were analyzed in GraphPad Prism or Microsoft 
Office Excel. Statistical significance was assumed at a P value of ≤ 0.05. P values were 
calculated with the unpaired t-test unless indicated otherwise. For interpretation of 
statistical results from unpaired t-test, * = p value ≤ 0.05, ** = p value ≤ 0.01, *** = p 









CHAPTER 4 - CONCLUSION 
The results described herein establish important biological functions of p120 catenin in 
pancreatic morphogenesis, homeostasis, and tumorigenesis. The mouse models generated 
in this study display both deficiency in p120 catenin and a reduction of adherens junction 
molecules allowing a unique model system to examine the biology of adherens junctions 
in vivo. We have shown that biallelic loss of p120 catenin during pancreatic development 
impaired pancreatic tubulogenesis and branching morphogenesis and manifested a 
biological role for p120 catenin in maintenance of adult pancreatic main ductal 
epithelium and regulation of pancreatitis. Induction of experimental pancreatitis in p120 
catenin depleted pancreata revealed a delayed regeneration capacity, suggesting a 
functional role for adherens junctions in recovery from pancreatic injury.  
Given the previous findings establishing p120 catenin as a tumor suppressor gene 
in murine oral cavity, squamous forestomach, and esophagus, it was unclear whether 
p120 catenin would have similar tumor suppressor activities in the pancreas. 
Development of frank PDAC was not observed with biallelic p120 catenin loss in either 
mouse model reported herein, suggesting that p120 catenin is not a bona fide tumor 
suppressor in pancreas. The inducible KCiMist1G; p120f/f mouse model developed in this 
study represents a new in vivo model to study epithelial cell delamination in early 
pancreatic neoplasia. The discovery that p120 catenin promotes invasion by regulating 
S1P/S1pr2 signaling yields important implications for identification of S1P/S1pr2 
signaling as a therapeutic target for PDAC. Because prior research has established low 
level expression of S1pr2 in human PDAC, further studies focused on examination of 
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small molecules to restore defective S1P/S1pr2 signaling in human PDAC will 
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